Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis 2 (ZOLARMAB2)

NCT05655013 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG: Zoledronate
DRUG: Placebo

Sponsor

Aarhus University Hospital